Novo Nordisk’s Options: A Look at What the Big Money is Thinking – Novo Nordisk (NYSE:NVO)

Deep-pocketed traders have adopted a bearish strategy in direction of Novo Nordisk NVO, and it is one thing market gamers should not ignore. Our monitoring of public choices data at Benzinga unveiled this vital transfer immediately. The id of those traders stays unknown, however such a considerable transfer in NVO often suggests one thing huge is about to occur.

We gleaned this info from our observations immediately when Benzinga’s choices scanner highlighted 20 extraordinary choices actions for Novo Nordisk. This stage of exercise is out of the atypical.

The final temper amongst these heavyweight traders is split, with 45% leaning bullish and 50% bearish. Amongst these notable choices, 15 are places, totaling $739,514, and 5 are calls, amounting to $274,325.

Predicted Value Vary

Making an allowance for the Quantity and Open Curiosity on these contracts, it seems that whales have been focusing on a value vary from $95.0 to $135.0 for Novo Nordisk over the past 3 months.

Analyzing Quantity & Open Curiosity

Inspecting the amount and open curiosity gives essential insights into inventory analysis. This info is essential in gauging liquidity and curiosity ranges for Novo Nordisk’s choices at sure strike costs. Under, we current a snapshot of the tendencies in quantity and open curiosity for calls and places throughout Novo Nordisk’s vital trades, inside a strike value vary of $95.0 to $135.0, over the previous month.

Novo Nordisk Choice Quantity And Open Curiosity Over Final 30 Days

Largest Choices Trades Noticed:

Image
PUT/CALL
Commerce Sort
Sentiment
Exp. Date
Ask
Bid
Value
Strike Value
Whole Commerce Value
Open Curiosity
Quantity

NVO
PUT
SWEEP
BULLISH
01/17/25
$6.2
$6.1
$6.1
$110.00
$151.2K
1.9K
559

NVO
PUT
TRADE
BULLISH
06/20/25
$4.45
$4.3
$4.31
$95.00
$86.1K
211
0

NVO
CALL
SWEEP
BULLISH
12/20/24
$6.0
$5.85
$5.93
$120.00
$69.5K
902
153

NVO
CALL
TRADE
BULLISH
03/21/25
$4.35
$4.25
$4.35
$135.00
$65.2K
908
151

NVO
PUT
TRADE
BEARISH
10/18/24
$2.52
$2.49
$2.52
$115.00
$62.7K
3.5K
581

About Novo Nordisk

With roughly one third of the worldwide branded diabetes remedy market, Novo Nordisk is the main supplier of diabetes-care merchandise on the planet. Primarily based in Denmark, the corporate manufactures and markets a wide range of human and trendy insulins, injectable diabetes remedies comparable to GLP-1 remedy, oral antidiabetic brokers, and weight problems remedies. Novo additionally has a biopharmaceutical phase (constituting roughly 10% of income) that focuses on protein therapies for hemophilia and different issues.

Having examined the choices buying and selling patterns of Novo Nordisk, our consideration now turns on to the corporate. This shift permits us to delve into its current market place and efficiency

Novo Nordisk’s Present Market Standing

At present buying and selling with a quantity of 4,698,394, the NVO’s value is down by -0.73%, now at $114.24.
RSI readings recommend the inventory is at present could also be oversold.
Anticipated earnings launch is in 33 days.

Skilled Analyst Scores for Novo Nordisk

Within the final month, 3 consultants launched scores on this inventory with a median goal value of $160.0.

Flip $1000 into $1270 in simply 20 days?

20-year professional choices dealer reveals his one-line chart approach that reveals when to purchase and promote. Copy his trades, which have had averaged a 27% revenue each 20 days. Click on right here for entry.
* An analyst from Cantor Fitzgerald has revised its score downward to Chubby, adjusting the value goal to $160.
* An analyst from Cantor Fitzgerald has revised its score downward to Chubby, adjusting the value goal to $160.
* An analyst from Cantor Fitzgerald downgraded its motion to Chubby with a value goal of $160.

Buying and selling choices entails larger dangers but in addition presents the potential for larger income. Savvy merchants mitigate these dangers by ongoing schooling, strategic commerce changes, using numerous indicators, and staying attuned to market dynamics. Sustain with the newest choices trades for Novo Nordisk with Benzinga Professional for real-time alerts.